At a glance
ClinicalIndex Comparison RecordN/ACompleted· 33 enrolled
Drug / intervention
Microwave ablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea
In Brief
A clinical study evaluating Microwave ablation for Carcinoma, Hepatocellular and 3 related conditions. Completed, enrolled 33 participants across 1 site.
Detailed Summary
This is a single arm, non-randomized, single center study to evaluate ablation, oncologic outcomes and safety in the treatment of hepatocellular carcinoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCarcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer, Cancer, Hepatocellular
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartDec 2017
First PostedJul 2018
Primary CompletionMay 2020
Study CompletionMay 2023
TodayJul 2026
First PostedJul 13, 2018
Enrollment StartDec 11, 2017
Primary CompletionMay 21, 2020
Study CompletionMay 11, 2023
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 8.0 years ago
Interventions
Microwave ablationdevice
All patients will receive microwave ablation using the NeuWave Microwave Ablation System and Accessories